A signature of estimate-stromal-immune score-based genes associated with the prognosis of lung adenocarcinoma

BACKGROUND: Immune and stromal component evaluation is necessary to establish accurate prognostic markers for the prediction of clinical outcomes in lung adenocarcinoma (LUAD). We aimed to develop a gene signature based on the Estimation of STromal and Immune cells in MAlignant Tumor tissues using E...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Qianli, Chen, Yang, Xiao, Fei, Hao, Yang, Song, Zhiyi, Zhang, Jin, Okuda, Katsuhiro, Um, Sang-Won, Silva, Mario, Shimada, Yoshihisa, Si, Chaozeng, Liang, Chaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044489/
https://www.ncbi.nlm.nih.gov/pubmed/33889524
http://dx.doi.org/10.21037/tlcr-21-223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044489/
https://www.ncbi.nlm.nih.gov/pubmed/33889524
http://dx.doi.org/10.21037/tlcr-21-223

Ejemplares similares